4.6 Review

Multimodality Intravascular Imaging of High-Risk Coronary Plaque

期刊

JACC-CARDIOVASCULAR IMAGING
卷 15, 期 1, 页码 145-159

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2021.03.028

关键词

coronary artery disease; fluorescence; multimodality imaging; near-infrared spectroscopy; optical; coherence tomography

资金

  1. National Health and Medical Research Council (NHMRC) [APP2001646]
  2. Australian Research Council [CE140100003]
  3. Hospital Research Foundation Group 2020 translational project grant
  4. National Heart Foundation of Australia [102093, FLF102056]
  5. Netherlands Heart Institute Fellowship
  6. Lin Huddleston Senior Fellowship from the National Heart Foundation of Australia
  7. NHMRC [GNT1174098, 1111630, APP1178912, APP2002254, CDF1161506]
  8. AstraZeneca
  9. Amgen
  10. Anthera
  11. CSL Behring
  12. Cerenis
  13. Eli Lilly
  14. Esperion
  15. Resverlogix
  16. Novartis
  17. InfraReDx
  18. Sanofi-Regeneron
  19. Abbott Vascular
  20. National Health and Medical Research Council of Australia [1111630] Funding Source: NHMRC

向作者/读者索取更多资源

This review examines emerging hybrid intracoronary imaging techniques and discusses their strengths, limitations, and potential for clinical translation, aiming to advance clinical approaches for predicting atherothrombotic events and improving the treatment of coronary atherosclerosis.
The majority of coronary atherothrombotic events presenting as myocardial infarction (MI) occur as a result of plaque rupture or erosion. Understanding the evolution from a stable plaque into a life-threatening, high-risk plaque is required for advancing clinical approaches to predict atherothrombotic events, and better treat coronary atherosclerosis. Unfortunately, none of the coronary imaging approaches used in clinical practice can reliably predict which plaques will cause an MI. Currently used imaging techniques mostly identify morphological features of plaques, but are not capable of detecting essential molecular characteristics known to be important drivers of future risk. To address this challenge, engineers, scientists, and clinicians have been working hand-in-hand to advance a variety of multimodality intravascular imaging techniques, whereby 2 or more complementary modalities are integrated into the same imaging catheter. Some of these have already been tested in early clinical studies, with other next-generation techniques also in development. This review examines these emerging hybrid intracoronary imaging techniques and discusses their strengths, limitations, and potential for clinical translation from both an engineering and clinical perspective. (J Am Coll Cardiol Img 2022;15:145-159) (c) 2022 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据